Adicet Bio, Inc. Public Float
Adicet Bio, Inc. (ACET) had Public Float of $50.50 million as of 2025-06-30, per its 10-K/A filed 2026-05-20.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-05-20
- 2025-06-30: Entity Public Float $50.50M.
- 2024-06-30: Entity Public Float $84.40M.
- 2023-06-30: Entity Public Float $76.70M.
- 2022-06-30: Entity Public Float $427.70M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $50.50M 10-K/A · filed 2026-05-20 |
| 2024-06-30 | $84.40M 10-K · filed 2025-03-06 |
| 2023-06-30 | $76.70M 10-K · filed 2024-03-19 |
| 2022-06-30 | $427.70M 10-K · filed 2023-03-15 |
| 2021-06-30 | $226.00M 10-K · filed 2022-03-15 |
| 2020-06-30 | $40.00M 10-K/A · filed 2021-08-16 |
| 2019-06-28 | $277.50M 10-K · filed 2020-03-12 |
| 2018-06-29 | $132.40M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |